Location History:
- Valley Park, MO (US) (2001 - 2002)
- Ballwin, MO (US) (2003 - 2006)
Company Filing History:
4 out of 200 
4 out of 2,198 
1 out of 2,538 Years Active: 2001-2006
Title: Innovator Scott A. Long: Pioneering Solutions in Anticoagulation Therapy
Introduction: Scott A. Long, an accomplished inventor based in Ballwin, MO, has made significant contributions to the field of biomedical science through his innovative research and patented inventions. With a total of nine patents to his name, Long's work primarily focuses on developing novel compounds for the selective inhibition of the coagulation cascade, offering promising solutions for treating thrombotic conditions.
Latest Patents: Among his recent innovations, two standout patents highlight his expertise. The first, titled "Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade," centers on compounds that inhibit serine proteases involved in the coagulation process. This invention aims to provide advanced anticoagulant therapies for the treatment and prevention of various thrombotic conditions, such as coronary artery and cerebrovascular diseases.
His second notable patent, "Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade," encompasses compounds and prodrugs that prevent and treat thrombotic conditions in mammals. These innovative compounds selectively target specific proteases within the coagulation cascade, further contributing to the advancement of anticoagulant therapies.
Career Highlights: Scott A. Long's professional journey includes collaborations with renowned organizations such as Pharmacia Corporation and SmithKline Beecham Corporation. His extensive experience in these companies has played a crucial role in shaping his research and fostering a deeper understanding of medicinal chemistry.
Collaborations: Throughout his career, Long has worked alongside esteemed colleagues, including Michael S. South and Horng-Chih Huang. Their collaborative efforts have led to significant advancements in the development of anticoagulant therapies and have enriched the scientific community's understanding of coagulation mechanisms.
Conclusion: Scott A. Long's dedication to innovation in the biomedical field is evident through his numerous patents and impactful research. As he continues to develop groundbreaking therapies for thrombotic conditions, his work not only advances medical science but also holds the potential to significantly improve patient outcomes in the realm of anticoagulation treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.